Generalization of D-, L- and DL-chlorpheniramine and zolantidine to the discriminative stimulus effects of cocaine and methamphetamine

Behavioural Pharmacology

Volumn 8, Issue 8, 1997, Pages 718-724

  Suzuki, T ^a   Mori, T ^a   Tsuji, M ^a   Misawa, M ^a   Onodera, K ^b  

^a HOSHI UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Chlorpheniramine; Cocaine; Drug discrimination; Methamphetamine; Rat; Zolantidine

Indexed keywords

APOMORPHINE; CHLORPHENIRAMINE; CLOMIPRAMINE; COCAINE; DESIPRAMINE; DEXCHLORPHENIRAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; METHAMPHETAMINE; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; VANOXERINE; ZOLANTIDINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG POTENCY; INTRAPERITONEAL DRUG ADMINISTRATION; ISOMER; MALE; NONHUMAN; PSYCHOPHARMACOLOGY; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BENZOTHIAZOLES; CHLORPHENIRAMINE; CLOMIPRAMINE; COCAINE; DESIPRAMINE; DISCRIMINATION (PSYCHOLOGY); DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENERALIZATION, STIMULUS; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; PHENOXYPROPANOLAMINES; PIPERAZINES; PIPERIDINES; RATS; RATS, INBRED F344; THIAZOLES;

EID: 0031460278     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199712000-00007     Document Type: Article

References (37)

1. Barnett A, Iorio LC, Kreutner W, Tozzi S, Ahn HS and Gulbenkian A (1984) Evaluation of the CNS properties of SCH29851, potential non-sedating antihistamine. Agents and Actions, 14, 590-597.
2. Bergman J and Spealman RD (1986) Some behavioral effects of histamine H1 antagonists in squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics, 239, 104-110.
3. 1 antagonists: comparison with other drugs and modification by haloperidol. Journal of Pharmacology and Experimental Therapeutics, 245, 471-478.
4. 2-receptor antagonist. British Journal of Pharmacology, 93, 69-78.
5. Colpaert FC, Niemegeers CJE and Janssen PAJ (1978) Discriminative stimulus properties of cocaine and D-amphetamine, and antagonism by haloperidol. A comparative study. Neuropharmacology, 17, 937-942.
6. Cunningham KA and Cullahan PM (1991) Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology, 104, 177-180.
7. Cunningham KA, Dworkin SI and Smith JE (1992) Neurobiology of cocaine: reinforcing and stimulus effects. In: Cocaine: Pharmacology, Physiology and Clinical Strategies (Eds JM Lakoski, MP Galloway and FJ White), pp. 91-113. CRC Press, London.
8. Douglas WW (1985) Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In: The Pharmacological Basis of Therapeutics (Eds AF Gilman, LS Goodman and A Gilman), pp. 604-673. Macmillan, New York.
9. 1-antagonists in animals trained to discriminate D-amphetamine or pentobarbital. Journal of Pharmacology and Experimental Therapeutics, 250, 779-787.
10. 2-receptors in opioid antinociception. Journal of Pharmacology and Experimental Therapeutics, 250, 476-484.
11. Goudie A and Reid D (1988) Qualitative discrimination between cocaine and amphetamine in rats. European Journal of Pharmacology, 151, 471-474.
12. Green JP, Johnson CL and Weinstein H (1979) Histamine as a neurotransmitter. In: Psychopharmacology: A Generation of Progress (Eds MA Lipton, A DiMascio and KF Killam), pp. 319-332. Raven Press, New York.
13. 1 receptors in guinea-pig brain. Journal of Neurochemistry, 31, 997-1004.
14. Iorio LC, Cohen-Winston M and Barnett A (1986) Interaction studies in mice of SCH29851, a potential non-sedating antihistamine, with commonly used therapeutic agents. Agents and Actions, 18, 485-493.
15. Jarbe TUC and Swedberg MDB (1982) Discriminative stimulus properties of drug: a brief history and selective review. Scandinavian Journal of Psychology, 1 (Suppl), 72-78.
16. Masukawa Y, Suzuki T and Misawa M (1993) Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines. Psychopharmacology, 111, 139-143.
17. 1 antagonists on operant behavior in the squirrel monkey. Psychopharmacology, 77, 156-158.
18. 1 antagonists as behavioral stimulants in the squirrel monkey. Psychopharmacology, 86, 380-381.
19. Nielsen EB and Scheel-Kruger J (1987) CNS stimulants: neuropharmacological mechanisms. In: Transduction Mechanism of Drug Stimuli (Eds FC Colpaert and PL Balster), pp. 57-72. Springer-Verlag, Berlin.
20. 3H-mepyramine may predict sedative properties of psychotropic drugs. European Journal of Pharmacology, 60, 391-392.
21. Ritz MC and Kuhar MJ (1989) Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. Journal of Pharmacology and Experimental Therapeutics, 248, 1010-1017.
22. Sakurai E, Yamasaki S, Hikichi N and Onodera K (1991) Effects of D-, L-, and DL-chlorpheniramine on dopamine and 3,4-dihydroxyphenylacetic acid levels in regional parts of rat brain. Tohoku Journal of Experimental Medicine, 163, 239-244.
23. Sansone M, Castellano C and D'Amato FR (1986) Enhancement of morphine-induced hyperactivity by antihistaminic drugs in mice. Archives Internationales de Pharmacodynamie et de Therapie, 284, 239-245.
24. 1-receptor antagonists on monoamine metabolism in the mouse brain. Naunyn-Schmiedeberg's Archives of Pharmacology, 343, 185-189.
25. Suzuki T, Mori T, Funada M, Misawa M and Nagase H (1994) Attenuation of the discriminative stimulus properties of cocaine by D-opioid receptor antagonists. European Journal of Pharmacology, 263, 207-211.
26. Suzuki T, Takamori K, Misawa M and Onodera K (1995) Effects of the histaminergic system on the morphine-induced conditioned place preference in mice. Brain Research, 675, 195-202.
27. 1-antagonists on discriminative stimulus effects of cocaine and methamphetamine in rats. Behavioural Pharmacology, 7, 111-118.
28. 1-antagonists and opioids: a drug discrimination study. Psychopharmacology, 131, 346-353.
29. Suzuki T, Mori T, Tsuji M, Maeda J, Kishimoto Y, Misawa M and Nagase H (1997b) Differential effects of μ-, δ- and κ-opioid receptor agonists on discriminative stimulus properties of cocaine in rats. European Journal Pharmacology, 324, 21-29.
30. Symchowicz S, Korduba CA, and Veals J (1971) Inhibition of dopamine uptake into synaptosomes of rat corpus striatum by chlorpheniramine and its structural analogs. Life Sciences, 10, 35-42.
31. Tuomisto J and Tuomisto L (1980) Effects of histamine and histamine antagonists on the uptake and release of catecholamines 5-HT in brain synaptosomes. Medical Biology, 58, 33-37.
32. White JM (1985) The discriminative properties of mepyramine. Life Sciences, 37, 1145-1153.
33. Witkin JM, Nichols DE, Terry P and Katz JL (1991) Behavioral effects of selective dopaminergic compounds in discriminating cocaine injections. Journal of Pharmacology and Experimental Therapeutics, 257, 706-713,
34. Wood DM and Emmett-Oglesby (1986) Characteristics of tolerance, recovery from tolerance and cross-tolerance for cocaine used as a discriminative stimulus. Journal of Pharmacology and Experimental Therapeutics, 237, 120-125.
35. Woolverton WL and Cervo L (1986) Effects of central dopamine depletion on the D-amphetamine discriminative stimulus in rats. Psychopharmacology, 88, 196-200.
36. Young R and Glennon RA (1986) Discriminative stimulus properties of amphetamine and structually related phenylalkylamines. Medical Research Review, 6, 99-130.
37. 1-antihistamines in cocaine-trained pigeons. Behavioural Pharmacology, 1, 261-265.